Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FloGraft in Knee Osteoarthritis
NCT03441607Phase 2Unknown
- Sponsor
- Applied Biologics
- Start
- Nov 2018
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in osteoarthritis (OA) (2 arms), sponsored by Applied Biologics. Primary endpoint: Visual Analogue Scale at 3 months. Status: unknown.
02
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03441607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03441607.